New MS Drug Could Help Biogen Stock

View Comments

CBS Boston (con't)

Affordable Care Act Updates:

Health News & Information:

For The Family

BOSTON (CBS) – Multiple sclerosis is a devastating disease, but a pharmaceutical based here in Massachusetts is developing a drug that they hope will ease suffering for a lot of MS patients.

Biogen Idec has just announced that this drug is a step closer to being approved. How will the news impact the company’s stock?

Lisa van der Pool of the Boston Business Journal reports:

View Comments
blog comments powered by Disqus